Next Article in Journal
Complexity in Estimation of Esomeprazole and its Related Impurities' Stability in Various Stress Conditions in Low-Dose Aspirin and Esomeprazole Magnesium Capsules
Previous Article in Journal
Synthesis of Diarylpyrazoles Containing a Phenylsulphone or Carbonitrile Moiety and their Chalcones as Possible Anti-Inflammatory Agents
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Open AccessArticle

Validation of a Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Trimethoprim and Sulfadimethoxine Sodium in Oral Liquid Dosage Form

1
Pharmacare Pharmaceutical Company, P.O. Box 677, Ramallah, Palestine
2
Faculty of Pharmacy, Al-Quds University, P.O. Box 20002, Abu-Dies, Palestine
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2013, 81(2), 459-474; https://doi.org/10.3797/scipharm.1212-30
Received: 31 December 2012 / Accepted: 18 February 2013 / Published: 18 February 2013
A simple, specific, accurate, and stability-indicating RP-HPLC method was developed and validated for the simultaneous determination of Trimethoprim (TMP) and Sulfadimethoxine sodium (SDMS) in Vetricine® oral solution product. The desired separation was achieved on an ODS column (250×4.6 mm i.d., 5 μm) at room temperature. The optimized mobile phase consisted of an isocratic solvent mixture of water:acetonitrile:triethylamine (700:299:1, v/v/v), adjusted to a pH of 5.7 ± 0.05 with 0.2N acetic acid. The mobile phase was fixed at 0.8 ml/min and the analytes were monitored at 254 nm using a photodiode array detector. The effects of the chromatographic conditions on the peaks USP tailing factor, column efficiency, and resolution were systematically optimized. Forced degradation experiments were carried out by exposing TMP, SDMS standards, and the oral solution formulation to thermal, photolytic, oxidative, and acid-base hydrolytic stress conditions. The degradation products were well-resolved from the main peaks and the excipients, thus proving the reliable stability-indicating method. The method was validated as per ICH and USP guidelines (USP34/NF29) and found to be adequate for the routine quantitative estimation of TMP and SDMS in commercially available Vetricine® oral liquid dosage form.
Keywords: Trimethoprim; Sulfadimethoxine sodium; Vetricine® oral solution; Validation; Stability indicating method Trimethoprim; Sulfadimethoxine sodium; Vetricine® oral solution; Validation; Stability indicating method
MDPI and ACS Style

GHANEM, M.M.; ABU-LAFI, S.A. Validation of a Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Trimethoprim and Sulfadimethoxine Sodium in Oral Liquid Dosage Form. Sci. Pharm. 2013, 81, 459-474. https://doi.org/10.3797/scipharm.1212-30

AMA Style

GHANEM MM, ABU-LAFI SA. Validation of a Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Trimethoprim and Sulfadimethoxine Sodium in Oral Liquid Dosage Form. Scientia Pharmaceutica. 2013; 81(2):459-474. https://doi.org/10.3797/scipharm.1212-30

Chicago/Turabian Style

GHANEM, Mashhour M.; ABU-LAFI, Saleh A. 2013. "Validation of a Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Trimethoprim and Sulfadimethoxine Sodium in Oral Liquid Dosage Form" Sci. Pharm. 81, no. 2: 459-474. https://doi.org/10.3797/scipharm.1212-30

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop